168 related articles for article (PubMed ID: 35456281)
41. Quality of life in purely ocular myasthenia in Japan.
Suzuki S; Murai H; Imai T; Nagane Y; Masuda M; Tsuda E; Konno S; Oji S; Nakane S; Motomura M; Suzuki N; Utsugisawa K
BMC Neurol; 2014 Jul; 14():142. PubMed ID: 24996227
[TBL] [Abstract][Full Text] [Related]
42. Quality of life in 188 patients with myasthenia gravis in China.
Yang Y; Zhang M; Guo J; Ma S; Fan L; Wang X; Li C; Guo P; Wang J; Li H; Li Z
Int J Neurosci; 2016; 126(5):455-62. PubMed ID: 26000922
[TBL] [Abstract][Full Text] [Related]
43. Gender differences in quality of life among patients with myasthenia gravis in China.
Dong D; Chong MK; Wu Y; Kaminski H; Cutter G; Xu X; Li H; Zhao C; Yin J; Yu S; Zhu J
Health Qual Life Outcomes; 2020 Sep; 18(1):296. PubMed ID: 32883289
[TBL] [Abstract][Full Text] [Related]
44. Major motor-functional determinants associated with poor self-reported health-related quality of life in myasthenia gravis patients.
Cioncoloni D; Casali S; Ginanneschi F; Carone M; Veronica B; Rossi A; Giannini F
Neurol Sci; 2016 May; 37(5):717-23. PubMed ID: 27038315
[TBL] [Abstract][Full Text] [Related]
45. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Gratton SM; Herro AM; Feuer WJ; Lam BL
J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
[TBL] [Abstract][Full Text] [Related]
46. MG-ADL: still a relevant outcome measure.
Muppidi S; Wolfe GI; Conaway M; Burns TM;
Muscle Nerve; 2011 Nov; 44(5):727-31. PubMed ID: 22006686
[TBL] [Abstract][Full Text] [Related]
47. Lymphoplasma Exchange Improves Myasthenia Gravis Exacerbations: A Retrospective Study in a Chinese Center.
Ouyang S; Yin W; Zeng Q; Li B; Zhang J; Duan W; Li Y; Liang Y; Wang J; Tan H; Yang H
Front Immunol; 2022; 13():757841. PubMed ID: 35514988
[TBL] [Abstract][Full Text] [Related]
48. Translation, cross-cultural adaptation, and validation of the chinese version of the 15-item myasthenia gravis quality of life questionnaire.
Miao X; Lian Z; Liu J; Chen H; Shi Z; Li M; Zhou H; Hu X; Yang R
Muscle Nerve; 2019 Jan; 59(1):95-99. PubMed ID: 30055010
[TBL] [Abstract][Full Text] [Related]
49. Myasthenia Gravis Impairment Index: Sensitivity for Change in Generalized Muscle Weakness.
de Meel RHP; Barnett C; Bril V; Tannemaat MR; Verschuuren JJGM
J Neuromuscul Dis; 2020; 7(3):297-300. PubMed ID: 32250313
[TBL] [Abstract][Full Text] [Related]
50. Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis.
Katyal N; Narula N; Govindarajan R
J Neuromuscul Dis; 2021; 8(2):287-294. PubMed ID: 33325394
[TBL] [Abstract][Full Text] [Related]
51. Sensitivity of MG-ADL for generalized weakness in myasthenia gravis.
de Meel RHP; Raadsheer WF; van Zwet EW; Verschuuren JJGM; Tannemaat MR
Eur J Neurol; 2019 Jun; 26(6):947-950. PubMed ID: 30417962
[TBL] [Abstract][Full Text] [Related]
52. Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar.
Fatehi F; Moradi K; Okhovat AA; Shojatalab G; Sedighi B; Boostani R; Sarraf P; Haghi Ashtiani B; Ghasemi M; Moussavi S; Anjidani N; Nafissi S
Front Neurol; 2021; 12():682622. PubMed ID: 34512504
[No Abstract] [Full Text] [Related]
53. A new and easily used modified myasthenia gravis score.
Sathirapanya P; Wiputhanuphongs K; Liabsuetrakul T; Khanittanuphong P; Keeratichananont W
Neuromuscul Disord; 2020 Aug; 30(8):656-660. PubMed ID: 32771266
[TBL] [Abstract][Full Text] [Related]
54. Fatigue, self-efficacy and psychiatric symptoms influence the quality of life in patients with myasthenia gravis in Tianjin, China.
Fan X; Xing C; Yang L; Wang J; Feng L
J Clin Neurosci; 2020 Sep; 79():84-89. PubMed ID: 33070925
[TBL] [Abstract][Full Text] [Related]
55. Rest or 30-Min Walk as Exercise Intervention (RESTOREX) in Myasthenia Gravis: A Randomized Controlled Trial.
Misra UK; Kalita J; Singh VK; Kapoor A; Tripathi A; Mishra P
Eur Neurol; 2021; 84(3):168-174. PubMed ID: 33839731
[TBL] [Abstract][Full Text] [Related]
56. Physician- and self-assessed myasthenia gravis activities of daily living score.
Lee HL; Min JH; Seok JM; Cho EB; Cho HJ; Kim YD; Kim BJ
Muscle Nerve; 2018 Mar; 57(3):419-422. PubMed ID: 28796382
[TBL] [Abstract][Full Text] [Related]
57. Translation and validation of the 15-item Myasthenia Gravis Quality of life scale in Dutch.
Strijbos E; Gärtner FR; Verschuuren JJ
Muscle Nerve; 2018 Feb; 57(2):206-211. PubMed ID: 28271514
[TBL] [Abstract][Full Text] [Related]
58. Fatigue in myasthenia gravis: risk factors and impact on quality of life.
Hoffmann S; Ramm J; Grittner U; Kohler S; Siedler J; Meisel A
Brain Behav; 2016 Oct; 6(10):e00538. PubMed ID: 27781147
[TBL] [Abstract][Full Text] [Related]
59. Office-based respiratory assessment in patients with generalized myasthenia gravis.
Alcantara M; Barnett-Tapia C; Bril V; Mannan S; Shabanpour J; Riaz S; Ng E; Ryan C; Katzberg H
Neuromuscul Disord; 2024 Jul; 40():1-6. PubMed ID: 38776756
[TBL] [Abstract][Full Text] [Related]
60. [Correlation between oral corticosteroid therapy and present disease status in myasthenia gravis].
Imai T
Rinsho Shinkeigaku; 2013; 53(11):1306-8. PubMed ID: 24291969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
